SynthesisFrontiers in pediatrics2025
Neonatal phototherapy and cancer risk: a systematic review and meta-analysis.
Synthesis in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hyperbilirubinemia in premature infants <35 weeks' gestation: A chronologic age format for graphing consensus-based recommendations.Journal of perinatology : official journal of the California Perinatal Association · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the risk of cancer after phototherapy for neonatal hyperbilirubinemia. Study design: This was a systematic review and meta-analysis. Electronic databases, including PubMed, Embase, and Cochrane Library, were searched. Prospective and retrospective studies, case series, and review studies published between 1970 and 2025 were included. Studies underwent two stages of screening. The first phase was title and abstract screening. The second phase was a full-text review of studies deemed to meet the inclusion criteria. Risk of bias was assessed using ROBINS-E. Inverse-variance weighted multi-level random effects models were used for all analyses. Results: This systematic review and meta-analysis included 15 studies. Risk of bias was low in eight studies, one study was judged to have some concerns, and six studies were determined to have a high risk of bias. A total of 6,675,265 patient data points were included. Studies ranged from 1995-2022, with an age group from 35 weeks to 31 years old. Overall, there was an estimated 24% increased odds of cancer for those who received phototherapy compared to those who did not [OR = 1.24; 95% CI: (1.12, 1.36); Conclusions: Phototherapy for neonatal hyperbilirubinemia was associated with a small increased risk of cancer up to age 31 years. This association must be balanced by the well-understood risk of Bilirubin-Induced Neurologic Dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.